Neovastat oral blocker of angiogenesis: Phase I/II testing

Aeterna Laboratories Inc. (TSE:AEL), Sainte-Foy,

Read the full 54 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE